Nomura Securities downgraded Tetraphase Pharmaceuticals (NASDAQ: TTPH) from Buy to Neutral with a price target of $10.00 (from $54.00).Analyst M ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE